Jinhe Biotech Gets CSRC Nod for Private Placement; Eastern Zirconium Filing Accepted by SZSE

Jinhe Biotechnology said its application to issue shares to specific investors under the simplified procedure for 2025 has received registration approval from the China Securities Regulatory Commission, clearing the final regulatory hurdle. Separately, Eastern Zirconium announced that its private placement application has been accepted for review by the Shenzhen Stock Exchange, marking the first step in its review process. Both companies are seeking to raise capital through targeted share issuances.